Vice President, Head of Clinical Operations
Ray Therapeutics (RayTx) is a clinical-stage biotechnology company pioneering optogenetic gene therapies for blinding retinal diseases. RayTx aims to provide best-in-class and first-in-class, mutation-agnostic, vision restoration to patients without available treatment options. Founded in 2021 and headquartered in Berkeley, CA, the company raised $100 million in a Series A financing led by Novo Holdings in […]